Experimental Drug
- All
- News
- Videos
-
Elon Musk's Neuralink Gets FDA's 'Breakthrough Device' Tag for Implant Aimed at Restoring Vision
Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the US Food and Drug Administration's "breakthrough device" designation.
-
Drugmaker Gilead To Fund Monkeypox Education For LGBTQ+ Groups
Gilead is a leading producer of therapies to treat HIV. The company said it is also evaluating whether any of its treatments or experimental drug candidates could be effective against monkeypox.
-
10 Points On Dostarlimab, The Drug That 'Cured' Cancer During Trials
A study has found that a drug named Dostarlimab has helped treat rectal cancer. This has been described as a "first time in history"kind of result in cancer treatment with the disease simply vanishing in patients after the experimental treatment.
-
"First Time In History": Cancer Vanishes For Every Patient In Drug Trial
A small group of people with rectal cancer just experienced something of a miracle as their cancer simply vanished after an experimental treatment.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill
Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
-
Sensex Up Over 500 Points, Nifty Above 17,600; Divi's Labs, NTPC Top Gainers
Merck and company's partner Ridgeback Biotherapeutics said its experimental antiviral drug molnupiravir could halve chances of dying or being hospitalised; Divi's Laboratories makes the main ingredient of the drug
-
Why Merck's Covid Pill Is Seen As Such A Breakthrough
As Merck & Co. races ahead with an experimental pill that could play a pivotal role in the fight against Covid-19, efforts are intensifying to bring the drug to developing countries that have struggled to vaccinate their populations.
-
UK To Roll Out Life-Saving Covid Drug Given To Donald Trump
The treatment was used as part of the suite of experimental medicines given to Trump when he tested positive for COVID-19 last year.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
"Not Life-Saving Drug": Centre Clarifies On Remdesivir
Antiviral drug Remdesivir is not a life-saving drug and its "unnecessary or irrational" use on Covid patients is unethical, the centre tweeted on Monday, amid massive demand for the medicine triggered by an unprecedented surge in coronavirus cases.
-
Cadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes Disease
Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
-
No Big Correction Ahead, Say Analysts As Sensex Scales New Peak
US-based drug maker Pfizer's statement on Monday that its experimental COVID-19 vaccine showed over 90 per cent effectiveness based on initial trial results boosted global market sentiment.
-
Elon Musk's Neuralink Gets FDA's 'Breakthrough Device' Tag for Implant Aimed at Restoring Vision
Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the US Food and Drug Administration's "breakthrough device" designation.
-
Drugmaker Gilead To Fund Monkeypox Education For LGBTQ+ Groups
Gilead is a leading producer of therapies to treat HIV. The company said it is also evaluating whether any of its treatments or experimental drug candidates could be effective against monkeypox.
-
10 Points On Dostarlimab, The Drug That 'Cured' Cancer During Trials
A study has found that a drug named Dostarlimab has helped treat rectal cancer. This has been described as a "first time in history"kind of result in cancer treatment with the disease simply vanishing in patients after the experimental treatment.
-
"First Time In History": Cancer Vanishes For Every Patient In Drug Trial
A small group of people with rectal cancer just experienced something of a miracle as their cancer simply vanished after an experimental treatment.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill
Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
-
Sensex Up Over 500 Points, Nifty Above 17,600; Divi's Labs, NTPC Top Gainers
Merck and company's partner Ridgeback Biotherapeutics said its experimental antiviral drug molnupiravir could halve chances of dying or being hospitalised; Divi's Laboratories makes the main ingredient of the drug
-
Why Merck's Covid Pill Is Seen As Such A Breakthrough
As Merck & Co. races ahead with an experimental pill that could play a pivotal role in the fight against Covid-19, efforts are intensifying to bring the drug to developing countries that have struggled to vaccinate their populations.
-
UK To Roll Out Life-Saving Covid Drug Given To Donald Trump
The treatment was used as part of the suite of experimental medicines given to Trump when he tested positive for COVID-19 last year.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
"Not Life-Saving Drug": Centre Clarifies On Remdesivir
Antiviral drug Remdesivir is not a life-saving drug and its "unnecessary or irrational" use on Covid patients is unethical, the centre tweeted on Monday, amid massive demand for the medicine triggered by an unprecedented surge in coronavirus cases.
-
Cadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes Disease
Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
-
No Big Correction Ahead, Say Analysts As Sensex Scales New Peak
US-based drug maker Pfizer's statement on Monday that its experimental COVID-19 vaccine showed over 90 per cent effectiveness based on initial trial results boosted global market sentiment.
